Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: Implications for development of vaccine and diagnostic reagents

Immunology

Volumn 111, Issue 4, 2004, Pages 462-471

  Hussain, Rabia ^a   Shahid, Firdaus ^a   Zafar, Shahid ^b   Dojki, Maqboola ^a   Dockrell, Hazel M ^c  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b Marie Adelaide Leprosy Centre   (Pakistan)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN GROES; ASPARTYLLYSYLISOLEUCYLLEUCYLVALYLGLUTAMINYLALANYLASPARAGINYLGLUTAMYLALANYLG LUTAMYLTHREONYLTHREONYLTHREONYLALANINE; ASPARTYLLYSYLISOLEUCYLLEUCYLVALYLGLUTAMINYLALANYLGLYCYLGLUTAMYLALANYLGLUTAM YLTHREONYLMETHIONYLTHREONYLPROLINE; BCG VACCINE; CYTOKINE; EPITOPE; GAMMA INTERFERON; GLUTAMYLTHREONYLMETHIONYLTHREONYLPROLYLSERYLGLYCYLLEUCYLVALYLISOLEUCYLPROLY LGLUTAMYLASPARAGINYLALANYLLYSINE; GLUTAMYLTHREONYLTHREONYLTHREONYLALANYLSERYLGLYCYLLEUCYLVALYLISOLEUCYLPROLYL ASPARTYLTHREONYLALANYLLYSINE; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; LEUCYLASPARTYLALANYLSERYLGLUTAMYLGLYCYLASPARTYLTHREONYLVALYLISOLEUCYLTYROSY LSERYLLYSYLTYROSYLGLYCINE; MYCOBACTERIUM ANTIGEN; PEPTIDE; PROLYLASPARTYLTHREONYLALANYLLYSYLGLUTAMYLLYSYLPROLYLGLUTAMINYLGLUTAMYLGLYCY LTHREONYLVALYLVALYLALANINE; PROLYLGLUTAMYLASPARAGINYLALANYLLYSYLGLUTAMYLLYSYLPROLYLGLUTAMINYLGLUTAMYLGL YCYLTHREONYLVALYLVALYLALANINE; REAGENT; TRYPTOPHYLASPARTYLGLUTAMYLASPARTYLGLYCYLALANYLLYSYLARGINYLPROLYLVALYLASPART YLVALYLSERYLGLUTAMINE; TRYPTOPHYLASPARTYLGLUTAMYLASPARTYLGLYCYLGLUTAMYLLYSYLARGINYLISOLEUCYLPROLYL VALYLLEUCYLVALYLALANYLGLUTAMINE; UNCLASSIFIED DRUG; VALYLALANYLLYSYLVALYLLYSYLASPARAGINYLLYSYLPROLYLLEUCYLGLUTAMYLASPARTYLLYSYL ISOLEUCYLLEUCYLVALINE; VALYLALANYLLYSYLVALYLLYSYLISOLEUCYLLYSYLPROLYLLEUCYLGLUTAMYLASPARTYLLYSYLIS OLEUCYLLEUCYLVALINE; VALYLASPARTYLVALYLSERYLGLUTAMYLGLYCYLASPARTYLISOLEUCYLVALYLISOLEUCYLTYROSYL SERYLLYSYLTYROSYLGLYCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG POTENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; LEPROSY; MACROPHAGE ACTIVATION; MOLECULAR RECOGNITION; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; VACCINE PRODUCTION;

AMINO ACID SEQUENCE; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BACTERIAL PROTEINS; CYTOKINES; GROES PROTEIN; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOGLOBULIN G; LEPROSY; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY;

EID: 1842734401     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0019-2805.2004.01839.x     Document Type: Article

References (26)

1. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of IFN gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. J Exp Med 1989; 169:59-72.
2. + subset expression in murine Candidiasis: Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J Immunol 1993; 150:925-31.
3. Myvang B, Godal T, Ridley DS, Froland SS, Song YK. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Clin Exp Immunol 1973; 14:541-53.
4. Melsom R, Harboe M, Myrvang B, Godal T, Belehu A. Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the intermediate group and healthy contacts as a step in the development of methods for serodiagnosis of leprosy. Clin Exp Immunol 1982; 47:225-33.
5. Hussain R, Kifayet A, Chiang T. Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy. Infect Immun 1995; 63:410-5.
6. Hunter SW, Rivoire B, Mehra V, Bloom BR, Brennan PJ. The major native proteins of the leprosy bacillus. J Biol Chem 1990; 265: 14065-8.
7. Pessolani MCV, Brennan PJ. Molecular definition and identification of new proteins of Mycobacterium Leprae. Infect Immun 1996; 64: 5425-7.
8. Rivoire B, Pessolani MCV, Bozic CM, Hunter SW, Hefta SA, Mehra V, Brennan P. Chemical definition, cloning, and expression of the major protein of the leprosy bacillus. Infect Immun 1994; 62:2417-25.
9. Young RA, Sweetser D, Mehra V, Buchanan T, Davis RW, Bloom BR. Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature 1985; 316:450-2.
10. Young DB, Lathigra R, Hendrix R, Sweetser D, Young RA. Stress proteins are immune targets in leprosy and tuberculosis. Proc Natl Acad Sci USA 1988; 85:4267-70.
11. Gupta RS. Evolution of the chaperonin families (Hsp60, Hsp10 and Tcp-1) of protein and the origin of eukaryotic cells. Mol Microbiol 1995; 15:1-11.
12. Mayhew M, da Silva ACR, Martin J, Erdjument-Bromage H, Tempst P, Hartl FU. Protein folding in the central cavity of the GroEL-GroES chaperonin complex. Nature 1996; 379:420-6.
13. Mande SC, Bloom BR, Hol WGJ. Structure of the heat shock protein chaperonin-10 of Mycobacterium leprae. Science 1997; 271:203-7.
14. Mehra V, Bloom BR, Bajardi AC et al. A major T cell antigen of Mycobacterium leprae is a 10 kD heat shock cognate protein. J Exp Med 1992; 175:275-84.
15. Kim J, Sette A, Rodda S et al. Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue. J Immunol 1997; 159:335-43.
16. Launois P, N'Diaye MN, Cartel JL, Mane I, Drowart A, Van Vooren JP, Sarthou JL, Huygen K. Fibronectin binding antigen 85 and the 10-kilodalton GroES-related heat shock protein are the predominant TH-1 responses inducers in leprosy contacts. Infect Immun 1995; 63:88-93.
17. Hussain R, Dockrell HM, Chiang TJ. Dominant recognition of a cross-reactive B cell epitope in Mycobacterium leprae 10 K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy. Immunology 1999; 96:620-7.
18. Hussain RA, Kifayet M, Dojki and Dockrell HM. Selective correlation of interferon-γ tumour necrosis factor α and granulocyte macrophage colony-stimulating factor with immunoglobulin G1 and Immunoglobulin G3 subclass antibody in leprosy. Immunology 1999; 98:238-43.
19. Hussain R, Dockrell HM, Shahid F, Zafar S, Chiang TJ. Leprosy patients with lepromatous disease recognizes cross reactive T cell epitopes in the M. leprae GroES antigen. Clin Exp Immunol 1998; 114:204-9.
20. Chua-Intra B, Peerapakorn S, Davey N et al. T cell recognition of mycobacterial GroES peptides in Thai leprosy patients and contacts. Infect Immun 1988; 66:4903-9.
21. Pym AS, Brodin P, Majelessi L et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 2003; 9:533-9.
22. Fine PEM, Maine N, Ponnighaus JM, Clarkson JA. Protective efficacy of BCG against leprosy in Northern Malawi. Lancet 1986; 2: 499-502.
23. Fujieda S, Saxon A, Zhang K. Direct evidence that gamma 1 and gamma 3 switching in human B cell is interleukin-10 dependent. Mol Immunol 1996; 33:1335-43.
24. Skvaril F, Schilt U. Characterization of the subclasses and light chain types of IgG antibodies to rubella. Clin Exp Immunol 1984; 55:671-6.
25. Riesen WF, Skvaril F, Braun DG. Natural infection of man with group A Streptococci. Levels, restriction in class, subclass and type: and clonal appearance of polysaccaride group-specific antibodies. Scand J Immunol 1976; 5:383-90.
26. Hussain R, Menz B, Dockrell HM, Chiang TJ. Recognition of Mycobacterium leprae recombinant 18000 MW epitopes by IgG subclasses in leprosy. Immunology 1995; 84:290-7.